Welcome to Mehta Partners

With more than 2 decades of diverse experience & integrated perspectives on the BioPharma industry worldwide, our enduring commitment to our clients sets us apart.

We invite you to contact us to schedule a meeting or conference call.


 Viren Mehta

"Novartis and Sun Pharma agreed to a novel transaction conceptualized by MP team. Sun Pharma acquired 14 long-listed brands in Japan from Novartis for a total cash consideration of $293 million (see Press Release below). MP Advisors, led by Tarun Shah, solved a challenge facing many biopharma companies—how to establish a significant presence in Japan that will create a sustainable and growing infrastructure. " ... Read more

8 Apr 2016 | From the latest Perspectives entry by Viren Mehta, Sun Pharma enters Japanese Prescription Market